Inventor · disambiguated record
Jamie Knight
Also filed as: KNIGHT JAMIE · KNIGHT JAMIE D · KNIGHT JAMIE DAVID
12 granted patents·1 pending application·18 citations·filing 2006–2023
85Inventor score
Top patents by PatentIndex Score
13 records- 0193US11820751B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2022·Granted Nov 21, 2023·3 cites·6 claims
- 0286US9890152B2Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2015·Granted Feb 13, 2018·7 cites·29 claims
- 0384US12473269B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Nov 18, 2025·0 cites·12 claims
- 0483US12358884B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 0582US12351567B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Jul 8, 2025·0 cites·19 claims
- 0681US8557797B2Triazolopyridine derivatives and their therapeutic useFINCH HARRY·Filed 2010·Granted Oct 15, 2013·7 cites·20 claims
- 0770US10065970B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Sep 4, 2018·1 cites·18 claims
- 0859US11840527B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Dec 12, 2023·0 cites·8 claims
- 0958US11767316B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Sep 26, 2023·0 cites·9 claims
- 1050US10435414B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2018·Granted Oct 8, 2019·0 cites·23 claims
- 1145US9216992B2Thieno[3,2-c]pyridine potassium channel inhibitorsFORD JOHN·Filed 2006·Granted Dec 22, 2015·0 cites·11 claims
- 1240US2010056565A1Heterocyclic Derivatives as M3 Muscarinic ReceptorsARGENTA DISCOVERY LTD·Filed 2008·Application pending·0 cites
- 1335US11649237B2Substituted imidazo[1,5-a]pyrazines for IRE1 inhibitionOPTIKIRA LLC·Filed 2018·Granted May 16, 2023·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →